Rare diseases
Investigational molecules
Locations
Back to Sweden178 clinical trials in Umea, Sweden across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
SwedenStudy on the Effects of ION363 for Patients with Amyotrophic Lateral Sclerosis with Fused in Sarcoma Mutations
SwedenStudy on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)
SwedenStudy of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease
SwedenStudy on the Effects of Semaglutide in Patients with Early Alzheimer's Disease
SwedenStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
SwedenStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
SwedenStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
SwedenA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
SwedenStudy on the Safety and Effects of AMT-162 Gene Therapy for Adults with SOD1 ALS
SwedenStudy to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease
SwedenStudy on Mesalamine to Prevent Colorectal Cancer in Patients with Lynch Syndrome
SwedenThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on Amyotrophic Lateral Sclerosis (ALS), including studies of novel treatments like ION363, VHB937, and AMT-162. Research also explores therapeutic approaches for patients with specific genetic mutations.
Additional research includes investigations into ATTR amyloidosis with innovative treatments like vutrisiran and acoramidis.
Comprehensive studies in hematologic malignancies and solid tumors, including trials for chronic lymphocytic leukemia, follicular lymphoma, and breast cancer. Research in Stockholm examines innovative treatment approaches for various cancer types.
Notable focus on biomarker-guided treatments and targeted therapies for better patient outcomes.
Studies examining preventive approaches including HPV vaccination and screening programs. Research includes novel dengue fever vaccine trials and investigations into colorectal cancer prevention in Lynch syndrome patients.
Focus on population-level interventions and long-term disease prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
